A novel ultrasensitive derivatization-free synchronous fluorescence approach for the simultaneous analysis of propofol and nalbuphine in human plasma and dosage forms: Compliance with greenness and blueness metrics
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2025-11 · 340 · 126339
DOI: 10.1016/j.saa.2025.126339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2025-11. Verfasst von Mohamed A El Hamd und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia; Department of Pharmaceutical Analytical C…. Hauptthemen laut MEDLINE: Nalbuphine, Propofol. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Shaqra University, King Saud University, King Saud University Deanship of Scientific Research.
Abstract (Originalsprache)
This study presents a very sensitive and eco-friendly synchronous spectrofluorimetric method for the simultaneous quantification of propofol (PRP) and nalbuphine (NAL) for the first time. The technique used the intrinsic fluorescence characteristics of the two drugs, providing enhanced sensitivity and specificity. The two drugs were assessed simultaneously at 217 nm and 281 nm for PRP and NAL, respectively, with a synchronous wavelength difference (Δλ) of 80 nm. The proposed method was validated according to ICH Q2 (R2) requirements, exhibiting satisfactory accuracy, precision, linearity, and selectivity within the designated concentration ranges. The concentrations exhibited linearity within the ranges of 15.0-300.0 ng/mL and 0.5-16.0 µg/mL, with detection limits of 2.67 ng/mL and 0.15 µg/mL for PRP and NAL, respectively. The developed approach, owing to its great sensitivity, was utilized to assess the examined drugs in human plasma samples. The results demonstrated good bioanalytical applicability, exhibiting high recovery percentages (98.40-101.70) and low relative standard deviation (%RSD) values (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, South Valley University, Qena 83523, Eg…
- Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh 33511, Egypt. Electronic address: galal_magdy@pharm.kfs.edu.eg.
- Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt. Electronic address: dr_m_hamed@mans.edu.eg.
- Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Tanta University, Tanta 31111, Egypt; Department of Medicinal Chemistry, Faculty of Pharmacy, King Salman International University (KSIU), South Sinai…
- Department of Chemistry, Faculty of Science, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia.
- Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Förderung
- Shaqra University
- King Saud University
- King Saud University Deanship of Scientific Research
Zitieren
APA
El Hamd, M. A., Magdy, G., El-Maghrabey, M., Mansour, F. R., Al-Khateeb, L. A., Mahdi, W. A., Alshehri, S., Alsehli, B. R., & Radwan, A. S. (2025). A novel ultrasensitive derivatization-free synchronous fluorescence approach for the simultaneous analysis of propofol and nalbuphine in human plasma and dosage forms: Compliance with greenness and blueness metrics. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 340, 126339. https://doi.org/10.1016/j.saa.2025.126339
Vancouver
El Hamd MA, Magdy G, El-Maghrabey M, Mansour FR, Al-Khateeb LA, Mahdi WA, et al. A novel ultrasensitive derivatization-free synchronous fluorescence approach for the simultaneous analysis of propofol and nalbuphine in human plasma and dosage forms: Compliance with greenness and blueness metrics. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2025;340:126339. doi:10.1016/j.saa.2025.126339
BibTeX
@article{ElHamd2025,
author = {El Hamd, Mohamed A and Magdy, Galal and El-Maghrabey, Mahmoud and Mansour, Fotouh R and Al-Khateeb, Lateefa A and Mahdi, Wael A and Alshehri, Sultan and Alsehli, Bandar R and Radwan, Aya Saad},
title = {A novel ultrasensitive derivatization-free synchronous fluorescence approach for the simultaneous analysis of propofol and nalbuphine in human plasma and dosage forms: Compliance with greenness and blueness metrics},
journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
year = {2025},
volume = {340},
pages = {126339},
doi = {10.1016/j.saa.2025.126339}
}
EUVIMED